{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:52:30Z","timestamp":1793267550138,"version":"4.5.0"},"reference-count":95,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Centres for Disease Control and Prevention Overdose Data to Action","award":["NU17CE925000"],"award-info":[{"award-number":["NU17CE925000"]}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K24DA042720"],"award-info":[{"award-number":["K24DA042720"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Annals of Medicine"],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.1080\/07853890.2022.2121417","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T03:41:04Z","timestamp":1663299664000},"page":"2450-2468","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Primary care management of Long-Term opioid therapy"],"prefix":"10.1080","volume":"54","author":[{"given":"Phillip O.","family":"Coffin","sequence":"first","affiliation":[{"name":"San Francisco Department of Public Health, Center on Substance Use and Health","place":["San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca S.","family":"Martinez","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, Center on Substance Use and Health","place":["San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Wylie","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, Center on Substance Use and Health","place":["San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunny","family":"Ryder","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, Center on Substance Use and Health","place":["San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.7326\/L14-5016-8"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.3931"},{"key":"e_1_3_6_4_1","unstructured":"Radio NP. California doctors alarmed as state links their opioid prescriptions to deaths. 2021. https:\/\/www.npr.org\/sections\/health-shots\/2019\/01\/23\/687376371\/california-doctors-alarmed-as-state-links-their-opioid-prescriptions-to-deaths"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1464"},{"key":"e_1_3_6_6_1","doi-asserted-by":"crossref","unstructured":"Dowell D Ragan KR Jones CM et\u00a0al. CDC clinical practice guideline for prescribing opioids- United States 2022. https:\/\/www.regulations.gov\/document\/CDC-2022-0024-0002)","DOI":"10.15585\/mmwr.rr7103a1"},{"key":"e_1_3_6_7_1","volume-title":"AHRQ comparative effectiveness reviews, Number 209","author":"Skelly AC","year":"2018","unstructured":"Skelly AC, Chou R, Dettori JR, et\u00a0al. Noninvasive nonpharmacological treatment for chronic pain: a systematic review. In: AHRQ comparative effectiveness reviews, Number 209. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018."},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.23970\/AHRQEPCNONOPIOIDPHARMASURVEILLANCE3"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001851"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.0899"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000452"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-2-201001190-00006"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1904190"},{"key":"e_1_3_6_14_1","unstructured":"Opioid Workgroup of the Board of Scientific Counselors of the National Center for Injury Prevention and Control. Observations of the Opioid Workgroup of the Board of Scientific Counselors of the National Center for Injury Prevention and Control on the Updated CDC Guideline for Prescribing Opioids. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/injury\/pdfs\/bsc\/OWG-Report-of-Recs-1-12-06.30.21-FINAL-508.pdf"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2007.02.013"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2591"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pny231"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1151\/spp021113"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06251-w"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2017.1381663"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232538"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.05.001"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.11013"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05301-2"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m283"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.6928"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1811473"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2016.11.003"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12520"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-009-0981-1"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.3365"},{"key":"e_1_3_6_32_1","unstructured":"Venterans Administration. Opioid tapering decision tool. 2021. https:\/\/www.pbm.va.gov\/PBM\/AcademicDetailingService\/Documents\/Academic_Detailing_Educational_Material_Catalog\/52_Pain_Opioid_Taper_Tool_IB_10_939_P96820.pdf#"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002967"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1903654"},{"key":"e_1_3_6_35_1","unstructured":"US Department of Veterans Affairs. VA\/DoD clinical practice guidelines: management of opioid therapy for chronic pain. 2020. https:\/\/www.healthquality.va.gov\/guidelines\/Pain\/cot\/VADoDOTCPG022717.pdf"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-11-201006010-00004"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2019.1692122"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2012.01430.x"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06364-2"},{"issue":"3","key":"e_1_3_6_40_1","first-page":"S67","article-title":"American society of interventional pain physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2\u2013guidance","volume":"3","author":"Manchikanti L","year":"2012","unstructured":"Manchikanti L, Abdi S, Atluri S, et\u00a0al. American society of interventional pain physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2\u2013guidance. Pain Phys. 2012;3S;15(3S;7):S67\u2013S116.","journal-title":"Pain Phys"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/2050-6511-15-46"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2021.1.49652"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4642-8"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109090"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f174"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2021.306306a"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2015.1109648"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2019.09.007"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.13194"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-018-0730-4"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2016.11.003"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2017.01.022"},{"issue":"2","key":"e_1_3_6_53_1","first-page":"122","article-title":"Academic detailing pilot for naloxone prescribing among primary care providers in san francisco","volume":"49","author":"Behar E","year":"2017","unstructured":"Behar E, Rowe C, Santos GM, et\u00a0al. Academic detailing pilot for naloxone prescribing among primary care providers in san francisco. Fam Med. 2017;49(2):122\u2013126.","journal-title":"Fam Med"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-2771"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1972"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3107"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2017.1363218"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13193"},{"issue":"7","key":"e_1_3_6_60_1","first-page":"416","article-title":"Opioid use disorder: Medical treatment options","volume":"100","author":"Coffa D","year":"2019","unstructured":"Coffa D, Snyder H. Opioid use disorder: Medical treatment options. Am Fam Physician. 2019;100(7):416\u2013425.","journal-title":"Am Fam Physician"},{"key":"e_1_3_6_61_1","volume-title":"Federal regulation of methadone treatment","author":"Rettig RA","year":"1995","unstructured":"Rettig RA, Yarmolinsky A, editors. Federal regulation of methadone treatment. Washington, DC: National Academies Press; 1995."},{"key":"e_1_3_6_62_1","volume-title":"86th Annual Scientific Meeting of the College on Problems of Drug Dependence, Palm Springs CA","author":"Walker J","year":"2016","unstructured":"Walker J, Santos D, Rowe C, et\u00a0al. A novel approach to naltrexone injections may help to reduce complications and increase adherence. presented at: 86th Annual Scientific Meeting of the College on Problems of Drug Dependence, Palm Springs CA. 2016."},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108486"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14729"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.03910.x"},{"issue":"2","key":"e_1_3_6_66_1","first-page":"e13173","article-title":"Opioid use disorder: treatments and barriers","volume":"13","author":"Patel K","year":"2021","unstructured":"Patel K, Bunachita S, Agarwal AA, et\u00a0al. Opioid use disorder: treatments and barriers. Cureus. 2021;13(2):e13173. Feb 6","journal-title":"Cureus"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnaa089"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(93)90036-P"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000837"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13228"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13394"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2020.100179"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20081174"},{"key":"e_1_3_6_74_1","unstructured":"Food and Drug Administration. FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks. 2021. https:\/\/www.fda.gov\/media\/107888\/download"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.07.005"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109084"},{"key":"e_1_3_6_77_1","volume-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences Engineering and Medicine","year":"2022","unstructured":"National Academies of Sciences Engineering and Medicine. Medications for opioid use disorder save lives. Washington, DC: The National Academies Press. 2022."},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1890676"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.07.001"},{"key":"e_1_3_6_80_1","unstructured":"Substance Abuse and Mental Health Services Administration. Treatment Improvement Pro tocol 63: medications for opioid use disorder. US Department of Health and Human Services. 2022. https:\/\/store.samhsa.gov\/sites\/default\/files\/SAMHSA_Digital_Download\/PEP21-02-01-002.pdf"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2010.12.002"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000305"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13135"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000002718"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2021-103007"},{"key":"e_1_3_6_86_1","unstructured":"Clinical Practice Guideline. Management of Substance Use Disorders (Department of Veterans Affairs) 2021."},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.3655"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2020214"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-020-00317-y"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107700"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108413"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01774.x"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108307"},{"key":"e_1_3_6_94_1","unstructured":"State of California Health and Human Service Agency Department of Healthcare Services. Medi-Cal Contingency Management Pilot Program Policy Design. 2022. https:\/\/www.dhcs.ca.gov\/Documents\/DHCS-Contingency-Management-Policy-Paper.pdf"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.12.030"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109085"}],"container-title":["Annals of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/07853890.2022.2121417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T09:48:28Z","timestamp":1757324908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/07853890.2022.2121417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1080\/07853890.2022.2121417"],"URL":"https:\/\/doi.org\/10.1080\/07853890.2022.2121417","relation":{},"ISSN":["0785-3890","1365-2060"],"issn-type":[{"value":"0785-3890","type":"print"},{"value":"1365-2060","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iann20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iann20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}